Ireland’s cancer survival rates lag behind other EU countries with access to new drugs ‘limited’

20 October 2022 - Patient access to newer cancer medicines is limited and comes later in Ireland compared to other ...

Read more →

HSE weighs up impact of obesity drug that costs 250 Euros a month

31 July 2022 - Health authorities are evaluating whether a game changing new obesity drug should be used in Ireland ...

Read more →

Irish parents ‘breaking down and crying’ as children denied life changing cystic fibrosis medication

8 June 2022 - Sarah O’Keeffe found out that her son would not be getting the medication that would improve his ...

Read more →

Thousands sign petition demanding 35 kids with cystic fibrosis be given life-saving drug Kaftrio

2 June 2022 - 'The lives of our children are at stake here, and we need to have this drug'. ...

Read more →

'Intensive work' ongoing to give 35 children with cystic fibrosis access to life-changing drug

24 May 2022 - Health Minister Stephen Donnelly has said he wants to see the 35 children with cystic fibrosis ...

Read more →

Spravato approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder

16 May 2022 - Janssen has announced that Spravato (esketamine) nasal spray has been granted reimbursement in Ireland for the ...

Read more →

Just one in five new cancer treatments available to Irish patients

26 April 2022 - Delays in reimbursing new treatments may affect course of illnesses, study says. ...

Read more →

Irish cancer patients wait four months longer for access to new drugs than rest of Europe

11 April 2022 - Cancer patients in Ireland are waiting on average four months longer than people with the disease ...

Read more →

HSE approves reimbursement of Ajovy (fremanezumab) in migraine

11 November 2021 - Teva Pharmaceuticals Ireland has announced the approval of Ajovy (fremanezumab) 225 mg pre-filled syringe for prescription ...

Read more →

Tremfya (guselkumab) approved for reimbursement in Ireland for active psoriatic arthritis

11 November 2021 - The Janssen Pharmaceutical Companies of Johnson & Johnson have announced that Tremfya (guselkumab), a first-in-class treatment ...

Read more →

Minister for Health announces HSE approval to reimburse patisiran (Onpattro)

12 July 2021 - The Minister for Health, Stephen Donnelly TD is pleased to announce that the drug patisiran (Onpattro) ...

Read more →

State slower to ‘adopt new drugs’ than most of western Europe

31 May 2021 - Medicines regularly not worth approving at asking price. ...

Read more →

Ireland an outlier without access to new cell and gene therapy, report says

27 May 2021 - Upfront costs high but treatments may cut long-term expense and boost patient results. ...

Read more →

Irish pharmacists lobby for biosimilar substitution

17 August 2020 - Pharmacists in Ireland say the country is losing out on hundreds of millions of dollars in savings ...

Read more →

Sacubitril/valsartan (Entresto) utilisation and prescribing patterns in the context of a reimbursement application system

12 June 2020 - The aim of this study was to evaluate the utilisation of Entresto in Ireland and compare patient ...

Read more →